Mary M. Lyons

Array ( [id] => 18955567 [patent_doc_number] => 20240043894 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-02-08 [patent_title] => PRODUCTION OF NMN AND ITS DERIVATIVES VIA MICROBIAL PROCESSES [patent_app_type] => utility [patent_app_number] => 18/052595 [patent_app_country] => US [patent_app_date] => 2022-11-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 10466 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -19 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18052595 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 18564828 [patent_doc_number] => 20230255154 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-08-17 [patent_title] => SYSTEM AND METHOD FOR IN-SITU AMELIORATIONREMEDIATION OF SALINE-ALKALI SOIL USING MICROALGAE [patent_app_type] => utility [patent_app_number] => 17/973698 [patent_app_country] => US [patent_app_date] => 2022-10-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2421 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -9 [patent_words_short_claim] => 91 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17973698 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 18449632 [patent_doc_number] => 20230190908 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-06-22 [patent_title] => DNABII VACCINES AND ANTIBODIES WITH ENHANCED ACTIVITY [patent_app_type] => utility [patent_app_number] => 18/047619 [patent_app_country] => US [patent_app_date] => 2022-10-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 42111 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -50 [patent_words_short_claim] => 14 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18047619 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 19373919 [patent_doc_number] => 12065468 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2024-08-20 [patent_title] => Heme-binding small peptide [patent_app_type] => utility [patent_app_number] => 18/045914 [patent_app_country] => US [patent_app_date] => 2022-10-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 21 [patent_figures_cnt] => 21 [patent_no_of_words] => 24009 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 49 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18045914 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 18405823 [patent_doc_number] => 20230167174 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-06-01 [patent_title] => TREM2 STABILIZING ANTIBODIES [patent_app_type] => utility [patent_app_number] => 17/934795 [patent_app_country] => US [patent_app_date] => 2022-09-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 82227 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -37 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17934795 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 19615386 [patent_doc_number] => 20240401066 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-12-05 [patent_title] => STRAIN FOR PRODUCING HIGH CONCENTRATION L-GLUTAMIC ACID AND METHOD FOR PRODUCING L-GLUTAMIC ACID USING THE SAME [patent_app_type] => utility [patent_app_number] => 18/694893 [patent_app_country] => US [patent_app_date] => 2022-09-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 14531 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -7 [patent_words_short_claim] => 18 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18694893 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 18338255 [patent_doc_number] => 20230130204 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-04-27 [patent_title] => METHOD OF DIAGNOSING A DYSBIOSIS [patent_app_type] => utility [patent_app_number] => 17/942327 [patent_app_country] => US [patent_app_date] => 2022-09-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 15896 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -11 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17942327 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 18582927 [patent_doc_number] => 20230265184 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-08-24 [patent_title] => CHIMERIC ANTIGEN RECEPTORS WITH ENHANCED NFKB SIGNALING [patent_app_type] => utility [patent_app_number] => 17/929457 [patent_app_country] => US [patent_app_date] => 2022-09-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 28069 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -19 [patent_words_short_claim] => 19 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17929457 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 18033834 [patent_doc_number] => 20220378049 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-12-01 [patent_title] => PROTECTIVE BARRIER COMPOSITIONS, AND USES THEREOF [patent_app_type] => utility [patent_app_number] => 17/817719 [patent_app_country] => US [patent_app_date] => 2022-08-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 15168 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -18 [patent_words_short_claim] => 47 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17817719 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 18208498 [patent_doc_number] => 20230054756 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-02-23 [patent_title] => COMPOSITION FOR DIFFERENTIAL DIAGNOSIS OF ACANTHAMOEBA KERATITIS COMPRISING CHORISMATE MUTASE PROTEIN ANTIBODIES, AND ACANTHAMOEBA KERATITIS DIAGNOSIS KIT USING SAME [patent_app_type] => utility [patent_app_number] => 17/817459 [patent_app_country] => US [patent_app_date] => 2022-08-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2509 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -4 [patent_words_short_claim] => 17 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17817459 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 18179799 [patent_doc_number] => 20230040528 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-02-09 [patent_title] => METHODS TO SPECIFICALLY PROFILE PROTEASE ACTIVITY AT LYMPH NODES [patent_app_type] => utility [patent_app_number] => 17/816765 [patent_app_country] => US [patent_app_date] => 2022-08-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 12225 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -19 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17816765 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 19358574 [patent_doc_number] => 20240260608 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-08-08 [patent_title] => METHODS FOR THE REDUCTION OF METHANE PRODUCTION IN RUMINANTS [patent_app_type] => utility [patent_app_number] => 18/291870 [patent_app_country] => US [patent_app_date] => 2022-08-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8519 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -18 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18291870 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 18077372 [patent_doc_number] => 20220402984 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-12-22 [patent_title] => LYSIN-ANTIMICROBIAL PEPTIDE (AMP) POLYPEPTIDE CONSTRUCTS, LYSINS, ISOLATED POLYNUCLEOTIDES ENCODING SAME AND USES THEREOF [patent_app_type] => utility [patent_app_number] => 17/816318 [patent_app_country] => US [patent_app_date] => 2022-07-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 41667 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -9 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17816318 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 18449675 [patent_doc_number] => 20230190951 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-06-22 [patent_title] => CONJUGATES OF ANTIBODIES AN IMMUNE CELL ENGAGERS [patent_app_type] => utility [patent_app_number] => 17/812160 [patent_app_country] => US [patent_app_date] => 2022-07-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 50561 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -21 [patent_words_short_claim] => 85 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17812160 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 18091371 [patent_doc_number] => 20220409712 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-12-29 [patent_title] => BIOFUSION PROTEINS AS ANTI-MALARIA VACCINES [patent_app_type] => utility [patent_app_number] => 17/858642 [patent_app_country] => US [patent_app_date] => 2022-07-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11664 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -20 [patent_words_short_claim] => 51 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17858642 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 18311172 [patent_doc_number] => 20230115072 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-04-13 [patent_title] => Immunogenic Compositions of Polysaccharide-Protein Pegylated Compounds [patent_app_type] => utility [patent_app_number] => 17/857110 [patent_app_country] => US [patent_app_date] => 2022-07-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9260 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -25 [patent_words_short_claim] => 139 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17857110 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 17988901 [patent_doc_number] => 20220354938 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-11-10 [patent_title] => CELL-TARGETING MOLECULES COMPRISING DE-IMMUNIZED, SHIGA TOXIN A SUBUNIT EFFECTORS AND CD8+ T-CELL EPITOPES [patent_app_type] => utility [patent_app_number] => 17/852669 [patent_app_country] => US [patent_app_date] => 2022-06-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 147516 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -52 [patent_words_short_claim] => 111 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17852669 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 19674552 [patent_doc_number] => 12186390 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2025-01-07 [patent_title] => Vaccine delivery method [patent_app_type] => utility [patent_app_number] => 17/838890 [patent_app_country] => US [patent_app_date] => 2022-06-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 34 [patent_figures_cnt] => 64 [patent_no_of_words] => 17898 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 69 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17838890 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 17914692 [patent_doc_number] => 20220317087 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-10-06 [patent_title] => APPARATUS, SYSTEMS, AND METHODS FOR DETERMINING SUSCEPTIBILITY OF MICROORGANISMS TO ANTI-INFECTIVES [patent_app_type] => utility [patent_app_number] => 17/806206 [patent_app_country] => US [patent_app_date] => 2022-06-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 19734 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -18 [patent_words_short_claim] => 351 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17806206 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 17881217 [patent_doc_number] => 20220296694 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-09-22 [patent_title] => MYCOPLASMA BOVIS COMPOSITIONS [patent_app_type] => utility [patent_app_number] => 17/833002 [patent_app_country] => US [patent_app_date] => 2022-06-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 12976 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -10 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17833002 [rel_patent_id] =>[rel_patent_doc_number] =>)